drugset / Trial / NCT06896760
A Mass Balance Study of [14C]ABSK011
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-site, open-label, single-cohort, single-dose study to assess the absorption, metabolism, and excretion profile of \[14C\] ABSK011 in healthy adult male subjects. The study plans to enroll 6 to 8 healthy male subjects to ensure at least 6 evaluable subjects.
Timeline
- Start
- 2025-04-07
- Primary completion
- 2025-11-07
- Completion
- 2026-04-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABSK-011 | Unknown | 200 mg | Oral |
Indications
No indication recorded.